Cadmium-induced neurological disorders: Prophylactic role of taurine

Journal of Applied Toxicology

Volumn 28, Issue 8, 2008, Pages 974-986

  Sinha, Mahua ^a   Manna, Prasenjit ^a   Sil, Parames C ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Antioxidant; Cadmium; Cerebral oxidative stress; Neuro protection; Neuro toxin; Taurine

Indexed keywords

ASCORBIC ACID; CADMIUM; DIPHENYLAMINE; GLUTATHIONE DISULFIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TAURINE; THIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CONTROL GROUP; CONTROLLED STUDY; DNA DEGRADATION; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; IN VIVO STUDY; LIPID PEROXIDATION; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN CARBONYLATION; SCANNING ELECTRON MICROSCOPY; SINGLE DRUG DOSE;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BODY WEIGHT; BRAIN; CADMIUM CHLORIDE; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; LIPID PEROXIDATION; LIPID PEROXIDES; MALE; MALONDIALDEHYDE; MICE; MICROSCOPY, ELECTRON, SCANNING; NERVOUS SYSTEM DISEASES; ORGAN SIZE; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS; SUPEROXIDES; TAURINE;

MUS;

EID: 55549136435     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1363     Document Type: Article

References (69)

1. Acan NL, Tezcan EF. 1995. Inhibition kinetics of sheep brain glutathione reductase by cadmium ion. Bioch. Mol. Med. 54: 33-37.
2. Arabi M, Mohammadpour AA. 2006. Adverse effects of cadmium on bull spermatozoa. Vet. Res. Commun. 30: 943-951.
3. Aruoma OI, Halliwell B, Hoey BM, Butler J. 1988. The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem. J. 256: 251-255.
4. Barroso-Moguel R, Mwndez-Armenta M, Villeda-Hernandez J, Nava-Ruiz C, Santamaria A. 2002. Brain lesions induced by chronic cocaine administration to rats. Prog. Neuropsychopharmac. Biol. Psychiat. 26: 59-63.
5. Benzie IFF, Strain JJ. 1999. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Meth. Enzymol. 299: 15-27.
6. Bonaventura J, Schroeder WA, Fang S. 1972. Human erythrocyte catalase: an improved method of isolation and a revaluation of reported properties. Arch. Biochem. Biophys. 150: 606-617.
7. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
8. Calabrese V, Bates TE, Stella AMG. 2000. NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance. Neurochem. Res. 25: 1315-1341.
9. Casalino E, Calzaretti G, Sblano L, Landriscina C. 2000. Cadmium dependent enzyme activity alteration is not imputable to lipid peroxidation. Arch. Biochem. Biophys. 383: 288-295.
10. Casalino E, Calzaretti G, Sblano C, Landriscina C. 2002. Molecular inhibitory mechanisms of antioxidant enzymes in rat liver and kidney by cadmium. Toxicology 179: 37-50.
11. Chan HM, Cherian MG. 1992. Protective roles of metallothionein and glutathione in hepatotoxicity of cadmium. Toxicology. 72: 281-290.
12. Conrad ME, Schade SG. 1968. Ascorbic acid chelates in iron absorption: a role for hydrochloric acid and bile. Gastroenterology 55: 35-45.
13. Cozzi R, Ricordy R, Bartolini F et al. 1995. Taurine and ellagic acid: two differently-acting natural antioxidants. Environ. Mol. Mutagen. 26: 248-254.
14. Ellman GL. 1959. Tissue sulfhydryl group. Arch. Biochem. Biophys. 82: 70-77.
15. Esterbauer H, Cheeseman KH. 1990. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Meth. Enzymol. 186: 407-421.
16. Flohe L, Gunzler WA. 1984. Assay of glutathione peroxidase. Meth. Enzymol. 105: 114-121.
17. Flora SJS, Pande M, Bhadauria S, Kannan GM. 2004. Combined administration of taurine and meso 2,3-dimercaptosuccinic acid in the treatment of chronic lead intoxication in rats. Hum. Exp. Toxicol. 23: 157-166.
18. Fox MRS, Fry Jr BE. 1970. Cadmium toxicity decreased by dietary ascorbic acid supplements. Science 169: 989-991.
19. Fraga CG, Motchnik PA, Shigenaga MK, Helbock HJ, Jacob RA, Ames BN. 1991. Ascorbic acid protects against endogenous oxidative damage in human sperm. Proc. Natl. Acad. Sci. USA 88: 11003-11006.
20. Gabbiani G, Baic D, Dezxel C. 1967. Toxicity of cadmium for the central nervous system. Exp. Neurol. 18: 154-160.
21. Gennari A, Cortese E, Boveri M, Casado J, Prieto P. 2003. Sensitive endpoints for evaluating cadmium induced acute toxicity in LLCPK1 cells. Toxicology. 183: 211-220.
22. Gordon RE, Heller RF, Heller RF. 1992. Taurine protection of lungs in hamster models of oxidant injury: a morphologic time study of paraquat and bleomycin treatment. In Taurine: Nutritional Value and Mechanisms of Action, Lombardini JB, Schaffer SW, Azuma J (eds). Plenum Press: New York; 319-323.
23. Grosicki A. 2004. Influence of vitamin C on cadmium absorption and distribution in rats. Toxicology 18: 183-187.
24. Gulati S, Gill KD, Nath R. 1987. Effect of cadmium on lipid metabolism of brain: in vivo incorporation of labeled acetate into lipids. Pharmac. Toxicol. 60: 117-119.
25. Gupta P, Kar A. 1998. Role of ascorbic acid in cadmium induced thyroid dysfunction and lipid peroxidation. J. Appl. Toxicol. 18: 317-320.
26. Gutierrez-Reyes E, Albores A, Rios C. 1998. Increase of striatal dopamine release by cadmium in nursing rats ant its prevention by dexamethasone-induced metallothionein. Toxicology 131: 145-154.
27. Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione S-Transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249: 7130-7139.
28. Halliwell B, Gutteridge JMC. 1985. Oxygen radicals and the nervous system. Trends Neurosci. 8: 22-26.
29. Halliwell B, Wasil M, Grootveld M. 1987. Biologically significant scavenging of the myeloperoxidase derived oxidant hypochlorous acid by ascorbic acid. FEBS Lett. 213: 15-17.
30. Hissin PJ, Hilf RA. 1976. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74: 214-226.
31. Hu H. 2000. Exposure to metals. Primary Care 27: 983-996.
32. Huxtable RJ. 1992. Physiological action of taurine. Physiol. Rev. 72: 101-163.
33. Hwang DF, Wang LC. 2001. Effect of taurine on toxicity of cadmium in rats. Toxicology 167: 173-180.
34. Jiang ZY, Hunt JV, Wolff SP. 1992. Detection of lipid hydroperoxide using the FOX method. Anal. Biochem. 202: 384-389.
35. Kadrabova J, Madaric A, Ginter E. 1992. The effect of ascorbic acid on cadmium accumulation in guinea pig tissues. Experientia 48: 989-991.
36. Kakkar P, Das B, Viswanathan PN. 1984. A modified spectrophotometric assay of superoxide dismutase. Ind. J. Biochem. Biophys. 21: 130-132.
37. Kim JD, McCarter RJM, Yu BP. 1996. Influence of age, exercise and dietary restriction on oxidative stress in rats. Aging Clin. Exp. Res. 8: 123-129.
38. Klassen CD, Liu J. 1997. Role of metallothionein in cadmium induced hepatotoxicity and nephrotoxicity. Drug Metab. Rev. 29: 79-102.
39. LeBel CP, Bondy SC. 1990. Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem. Int. 17: 435-440.
40. Lee CY. 1982. Glucose-6-phosphate dehydrogenase from mouse. Meth. Enzymol. 89: 252-257.
41. Lima L, Obregon F, Cubillos S, Fazzino F, Jaimes I. 2001. Taurine as a micronutrient in development and regeneration of the central nervous system. Nutr. Neurosci. 4: 439-443.
42. Lin KT, Xue JY, Sun FF, Wong PYK. 1997. Reactive oxygen species participates in peroxynitrile induced apoptosis in HL 60 cells. Biochem. Biophys. Res. Commun. 230: 115-119.
43. Madesh M, Balasubramanian KA. 1997. A microlitre plate assay for superoxide using MTT reduction method. Ind. J. Biochem. Biophys. 34: 535-539.
44. Manca D, Ricard AC, Trottier B, Chevalier G. 1991. Studies on lipid peroxidation in rat tissues following administration of low and moderate doses of cadmium chloride. Toxicology 67: 303-323.
45. Mates JM. 2000. Effects of antioxidant enzymes in the molecular control of of reactive oxygen species. Toxicology 153: 83-84.
46. Mendez-Armenta M, Barroso-Moguel R, Villeda-Hernandez J, Nava-Ruiz C, Rios C. 2001. Histopathological alterations in the brain regions of rats after perinatal combined treatment with cadmium and dexamethasone. Toxicology 161: 189-199.
47. Moskovitz J, Yim MB, Chock PB. 2002. Free radicals and disease. Anal. Biochem. Biophys. 397: 354-359.
48. Nishikimi M, Rao NA, Yagi K. 1972. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commun. 46: 849-854.
49. Oshida A. 1974. Therapeutic effect of dietary iron and ascorbic acid on cadmium toxicity of rats. Nutr. Rep. Int. 10: 139-142.
50. Pari L, Murugavel P, Sitasawad SL, Kumar KS. 2007. Cytoprotective and antioxidant role of diallyl tetrasulfide on cadmium induced renal injury: an in vivo and in vitro study. Life Sci. 80: 650-658.
51. Patrick L. 2007. Toxic metals and antioxidants: Part II. The role of antioxidants in arsenic and cadmium toxicity. Altern Med Rev. 8: 106-128.
52. Quig D. 1998. Cysteine metabolism and metal toxicity. Altern. Med. Rev. 3: 262-270.
53. Redmond HP, Wang JH, Bouchier-Hayes D. 1996. Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury. Arch Surg 131: 1287-1288.
54. Sarkar S, Yadav P, Bhatnagar D. 1997. Cd induced lipid peroxidation and the antioxidant system in rat erythrocytes: role of antioxidants. J. Trace. Elem. Biol. 11: 8-13.
55. Sedlak J, Lindsay RH. 1958. Estimation of total, protein-bound, and non protein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 24/25: 192-205.
56. Sellins KS, Cohen JJ. 1987. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139: 3199-3206.
57. Shukla A, Shukla GS, Srimal RC. 1996. Cadmium-induced alterations in blood-brain barrier permeability and its possible correlation with decreased microvessel antioxidant potential in rat. Hum. Exp. Toxicol. 15: 400-405.
58. Smith IK, Vierheller TL, Thorne CA. 1988. Assay of glutathione reductase in crude tissue homogenates using 5,5′-dithiobis (2-nitrobenzoic acid). Anal. Biochem. 175: 408-413.
59. Son HY, Kim H, H Kwon Y. 2007. Taurine prevents oxidative damage of high glucose-induced cataractogenesis in isolated rat lenses. J. Nutr. Sci. Vitaminol. 53: 324-330.
60. Sorensen EMB, Smith NKR, Boecker CS, Acosta D. 1984. Calcium amelioration of cadmium induced cytotoxicity in cultured rat hepatocytes. In Vitro 20: 771-779.
61. Tacey E, White K, Baggs RB, Miller RK. 1990. Central nervous system lesions in the wister rat fetus following direct fetal injections of cadmium. Teratology 42: 7-13.
62. Timbrell JA, Seabra V, Waterfield CJ. 1995. The in vivo and in vitro protective properties of taurine. Gen. Pharmac. 26: 453-462.
63. Uchida K, Stadtman ER. 1993. Covalent attachment of 4-hydroxynonenal to glyceraldehydes-3-phosphate dehydrogenase. J. Biol. Chem. 268: 6388-6393.
64. U.S. Department of Health and Human Services. 1997. Toxicological profile for cadmium. Draft for Public Comment, Agency for Toxic Substances and Disease Registry, Atlanta.
65. Vohra BP, Hui X. 2001. Taurine protects against carbon tetrachloride toxicity in the cultured neurons and in vivo. Arch. Physiol. Biochem. 109: 90-94.
66. Wessberg P, Hedner T, Hedner J, Jonason. 1983. Effects of taurine and taurine antagonists on some respiratory and cardiovascular parameters. Life Sci. 33: 1649-1656.
67. WHO. 1992. Environmental Health Criteria 134, Cadmium, 1st edn. World Health Organization: Geneva.
68. Wong KL, Klaassen CD. 1982. Neurotoxic effects of cadmium in young rats. Toxicol. Appl. Pharmac. 63: 330-337.
69. Wright CE, Tallan HH, Linn YY. 1986. Taurine: biological update. A. Rev. Biochem. 55: 427-453.